Axim Cases and Covers in the News

Sat, 18 Nov 2017 12:05:42 GMT
This RSS feed URL is deprecatedThis RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

Thu, 26 Oct 2017 13:55:25 GMT
227 Marijuana Stocks: Not Even 1 Stock Is Trading Above The 2017 Year-To-Date High - Seeking Alpha

Seeking Alpha

227 Marijuana Stocks: Not Even 1 Stock Is Trading Above The 2017 Year-To-Date High
Seeking Alpha
More "winners" means taxpayers will be required to sell more "losers" to offset capital gains, rebalance their portfolios, and minimize cash outflows for April 15, 2018, in the case of taxable accounts. Therefore, there will be more tax loss selling or ...



Wed, 23 Nov 2016 16:11:44 GMT
Marijuana Stocks: Short AXIM Biotechnologies...If You Can Borrow And Finance The Shares - Seeking Alpha

Marijuana Stocks: Short AXIM Biotechnologies...If You Can Borrow And Finance The Shares
Seeking Alpha
You do not have to, in this case. The AXIM fundamentals are so horrible, it is unnecessary. However, the above chart is a classic parabolic rise, followed by a decline, followed by a slight recovery before continuing to proceed in a declining fashion ...



Tue, 27 Jun 2017 13:32:02 GMT
AXIM Biotechnologies (OTCQB: AXIM) Takes on Opioid Epidemic with New Patent -- SECFilings.com - Marketwired (press release)

AXIM Biotechnologies (OTCQB: AXIM) Takes on Opioid Epidemic with New Patent -- SECFilings.com
Marketwired (press release)
REDONDO BEACH, CA--(Marketwired - Jun 27, 2017) - SECFilings.com, a leading financial news and information portal offering free real time public company filing alerts, announces the publication of an article covering AXIM® Biotechnologies Inc. ( OTCQB ...

and more »


Tue, 21 Mar 2017 13:02:03 GMT
AXIM Biotech Retains Ora to Manage Upcoming Product Development and Clinical Trials on Glaucoma and Dry Eye ... - GlobeNewswire (press release)

AXIM Biotech Retains Ora to Manage Upcoming Product Development and Clinical Trials on Glaucoma and Dry Eye ...
GlobeNewswire (press release)
NEW YORK, March 21, 2017 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that it has retained the services of Ora®, Inc., a global Contract Research ...

and more »


Wed, 15 Nov 2017 14:21:12 GMT
FULL TEXT: 2018 Budget Statement - Peace FM Online

FULL TEXT: 2018 Budget Statement
Peace FM Online
“Rt. Hon. Speaker, Honourable Members of Parliament, on the authority of the President of the Republic, Nana Addo Dankwa Akufo-Addo, I beg to move that this Honourable House approves the Financial Policy of the Government of Ghana for the year ...



Sun, 08 Jan 2017 14:52:39 GMT
AXIM Biotech earns patent for chewing gum containing cannabinoids to treat neurodegenerative diseases - IPWatchdog.com

IPWatchdog.com

AXIM Biotech earns patent for chewing gum containing cannabinoids to treat neurodegenerative diseases
IPWatchdog.com
The patent space surrounding marijuana formulations for medical use is still wide open despite the current march towards legalization. According to patent portfolio analysis tools available through Innography, there are a total of 66 U.S. patent grants ...

and more »


Fri, 17 Mar 2017 14:38:29 GMT
Cannabinoid-based chewing gum enrolls patients in Ph II trial - In-PharmaTechnologist.com

In-PharmaTechnologist.com

Cannabinoid-based chewing gum enrolls patients in Ph II trial
In-PharmaTechnologist.com
George E. Anastassov, MD, CEO of AXIM Biotech, told us the main rationale behind using chewing gum as the delivery system for Cannabidiol (CBD) is that “the oral-pharyngeal mucosa offers​ extensive territory for rapid and controlled absorption of the ...

and more »


Thu, 14 Sep 2017 02:41:25 GMT
Biosynthesis Technology Could Transform Cannabinoid Production - Markets Insider

Biosynthesis Technology Could Transform Cannabinoid Production
Markets Insider
This could be a game changing development for companies operating within the burgeoning sector, including Axim Biotechnologies, Inc. (OTC: AXIM), GW Pharmaceuticals (NASDAQ: GWPH), Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE) and pharmaceutical ...

and more »


Tue, 17 May 2016 13:03:00 GMT
AXIM Biotech Begins Human Clinical Trials With Cannabigerol (CBG) for Psoriasis and Eczema in Patients - GlobeNewswire (press release)

AXIM Biotech Begins Human Clinical Trials With Cannabigerol (CBG) for Psoriasis and Eczema in Patients
GlobeNewswire (press release)
The two indications for AXIM's AX-1602 in human trials are Psoriasis (PsO) and atopic dermatitis (AD) also known as eczema. Collectively, these conditions will affect nearly two hundred million people worldwide by 2024; combined market estimates are ...
Medical Marijuana, Inc.'s Investment, AXIM Biotech, Launches World's First Cannabigerol (CBG) Clinical Trials on ...Marketwired (press release)

all 6 news articles »


Wed, 18 May 2016 10:24:26 GMT
Lou Moon Lodge - Telegraph.co.uk

Telegraph.co.uk

Lou Moon Lodge
Telegraph.co.uk
Most guests stay put but there are worthy excursions to be had nearby: Axim, with its 16th-century Portuguese trading post, Fort Santo Antonio – part of a multi-monument World Heritage site and one of Africa's oldest buildings – is a 30-minute drive ...